[The NPM1 mutation is generally used as a molecular marker in the prognosis evaluation of a patient with AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE